Events
|
Press Releases
|
For Healthcare Profesionals
Tuberculosis
T-SPOT®.TB
Economic Impact
Guidelines
The Learning Zone
Healthcare FAQs
For Healthcare Profesionals
For Consumers
About Tuberculosis
Active TB Disease and Latent TB Infection
Diagnosing Tuberculosis
Why Choose T-SPOT®.TB
TB Vaccination & Treatment
Patient Groups
Patient FAQs
For Consumers
For Media Members
Media Requests
For Media
The World Health Organization (WHO) estimates that more than one third of the world’s population is infected with Mycobacterium tuberculosis.

Press Releases

Oxford Immunotec Announces that the Centers for Medicare and Medicaid Services (CMS) Increases Reimbursement for the T-SPOT®.TB Test CPT® Code 86481 Federal Supply Schedule (FSS) Contract Awarded to Oxford Diagnostic Laboratories for T-SPOT®.TB Testing Study Results Show Switching from the Tuberculin Skin Test (TST) to an Interferon Gamma Release Assay (IGRA) can Improve Healthcare Worker Test Adherence at a Lower Cost UK’s NICE Recommend replacing Mantoux with TB blood tests for Key Patient Groups AMA establishes a new CPT® Code for use with the T-SPOT®.TB test Oxford Immunotec announces US FDA approval of PMA supplement for the use of the T-Cell Xtend® reagent Independent study demonstrates that T-SPOT®.TB assay outperforms TST in predicting TB disease The T-SPOT®.TB Test Now Included in New CDC Guidelines Independent peer-reviewed study demonstrates that TB contact tracing based on use of the T-SPOT®.TB assay is more cost effective Oxford Immunotec Closes Second Tranche of $26 Million Series D Financing Led by New Leaf Venture Partners New study confirms 98.9% specificity of the T-SPOT®.TB assay Oxford Immunotec announces contract with Scancell Ltd to measure T cell response in Phase I/II clinical immunotherapy trial 2010 World TB Day T-SPOT.TB is first IGRA to be Approved for Sale in Taiwan 2009 World TB Day 46 Articles
1 - 15 Next
Bookmark and Share
Get Email Updates
  • About
  • Products
  • Press Releases
  • Resources
  • Careers
  • Contact
  • Site Map
  • Terms of Use
  • Privacy Policy



T-SPOT®.TB, T-Cell Xtend™ and the Oxford Immunotec logo are trademarks of Oxford Immunotec | © 2010 Oxford Immunotec